t(4;10)(q12;q23) PDGFRA/TNKS2 by Chalmers, Zachary R et al.
Leukaemia Section 
Short Communication 
Atlas Genet Cytogenet Oncol Haematol. 2016; 20(4) 206 
Atlas of Genetics and Cytogenetics 
in Oncology and Haematology 
INIST-CNRS OPEN ACCESS JOURNAL 
t(4;10)(q12;q23) PDGFRA/TNKS2 
Zachary R Chalmers, Garrett M Frampton, Siraj M Ali, Robert Ohgami, Curtis R Miles 
Foundation Medicine, Inc. (ZRC, GMF, SMA); Stanford University School of Medicine (RO). 
Northwest Georgia Oncology Centers (CRM). Corresponding author: sali@foundationmedicine.com 
Published in Atlas Database: April 2015 
Online updated version : http://AtlasGeneticsOncology.org/Anomalies/t0410qq12q23ID1468.html 
Printable original version : http://documents.irevues.inist.fr/bitstream/handle/2042/62673/04-2015-t0410qq12q23ID1468.pdf 
DOI: 10.4267/2042/62673
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. 
© 2016 Atlas of Genetics and Cytogenetics in Oncology and Haematology 
Abstract 
Comprehensive genomic profiling identifies a novel 
PDGFRA-TNKS2 gene fusion in a female case of 
myeloid neoplasm with eosinophilia.  
The patient was treated with imatinib, and showed a 
dramatic and ongoing response with no evidence of 
disease 
Keywords 
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Identity 
Note 
This interchromosomal PDGFRA gene fusion is 
unlikely to be detected using surrogate CHIC2 
deletion FISH testing. 
Clinics and pathology 
Disease 
Myeloid neoplasm with eosinophilia 
Epidemiology 
One case to date: a 58-year-old female patient 
(Chalmers et al., 2015). 
Treatment 
Imatinib mesylate 
Evolution 
Complet remission, well tolerated response after 
treatment. No evidence of disease. 
Genes involved and 
proteins 
PDGFRA 
Location 
4q12 
Protein 
Member of the type III class of tyrosine kinase 
receptors.  
Functions as homo- and/or heterodimers depending 
on the cell type; activated by ligand-induced 
dimerization and autophosphorylation.  
Subsequent phosphorylation of its substrates 
initiates a variety of signal transduction cascades that 
promotes cell proliferation, survival and migration 
through the PI3K-AKT-mTOR and RAS-MAPK 
pathways as well as promotes activation of STAT 
family members (JAK/STAT) (Zamecnikova and 
Bahar, 2015). 
TNKS2 
Location 
10q23.3 
Protein 
Belongs to the poly(ADP-ribose)polymerase 
(PARP) protein super family.  
Role in the Wnt/beta-catenin signaling pathway. 
Roles of TNKS1 and TNKS2 in glucose homeostasis 
(Guo et al., 2012). 
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Intrachromosomal rearrangement of TNKS2 and PDGFRA. Fusion gene breakpoints are indicated by orange dashed line. ANK, 
ankyrin domains; ECD, extracellular domain; SAM, sterile alpha motif; TM, transmembrane; TNKS-L, tankyrase-like; TyKD, 
kinase domain. 
 
 
Result of the chromosomal 
anomaly 
Hybrid gene 
Description 
The hybrid gene fusion is a translocation of TNKS2 
and PDGFRA with breakpoint in intron 25 and exon 
12, respectively. The discovery of a novel fusion of 
TNKS2 with PDGFRA further demonstrates the 
diversity of alterations possible in these myeloid 
neoplasms with eosinophilia. 
Detection 
Comprehensive genomic profiling. 
Fusion protein 
See figure above. 
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